Advisory Board: Leslie Z. Benet, PhD
UC San Francisco (ret), Merck, Amgen, Boerhinger IngelheimDr. Benet, Professor and former chairman (1978-1998), Department of Biopharmaceutical Sciences, University of California, San Francisco (UCSF) has received international recognition for his work related to pharmacokinetics and pharmacodynamics-the processes by which the human body absorbs and eliminates drugs and the pharmacologic effects observed from those drugs. He is the recipient of six honorary doctorates, membership in the Institute of Medicine (IOM) of the U.S. National Academy of Sciences, listed among the most highly cited pharmacologists worldwide and recognized with the highest scientific awards of nine professional societies, including the Distinguished Pharmaceutical Scientist award of the American Association of Pharmaceutical Scientists, the Rawls-Palmer Progress in Medicine award of the American Society for Pharmacology and Therapeutics, the Higuchi research Prize of the American Pharmacists Association and the Host-Madsen Medal of the International Pharmaceutical Federation (FIP). In 2007 he was selected as the UCSF Distinguished Clinical Research Lecturer.
Dr. Benet formerly served as Chair of the Pharmacology Study Section and the Pharmacological Sciences Review Committee for the NIH, the FDA Center for Biologics (CBER) Peer Review Committee, the FDA Expert Panel on Individual Bioequivalence, the Board of Pharmaceutical Sciences of the FIP, the Organizing Committee for the Millenial World Congress of Pharmaceutical Sciences, the Congressionally mandated IOM/NRC Committee on Accelerating the Research, Development and Acquisition of Medical Countermeasures Against Biological Warfare Agents and as a member of the FDA Generic Drugs Advisory Committee and the FDA Science Board. He served as the Chair of the CBER subcommittee of the FDA Science Board that delivered its review of science at the FDA in December 2007. He was the Founder and first President of the American Association of Pharmaceutical Scientists that now numbers more than 13,000 members. Dr. Benet’s research interests and more than 490 scientific publications, 7 books and 11 patents are in the areas of pharmacokinetics, biopharmaceutics, drug delivery and pharmacodynamics.

